SFA Therapeutics

Summer 2021Active

Regulating the immune system to block cancer & autoimmune diseases

Save

SFA Therapeutics

Summer 2021Active

Regulating the immune system to block cancer & autoimmune diseases

Save

Company details

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.

Location

Philadelphia, PA, USA

Founded

Unknown

Request the SFA Therapeutics report.

SFA Therapeutics has no report yet. Sign in with your email to request one.